General contact

Novartis Pharmaceuticals Canada Inc.
385 Bouchard Blvd
Dorval, Quebec
H9S 1A9

(514) 631-6775
By e-mail : Response times may vary during holidays.
Resident of Canada

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Department of Communications
Novartis Pharmaceuticals Canada Inc.
385 Bouchard Blvd.
Dorval, Quebec H9S 1A9

Pharmaceuticals

Over the past decade, Novartis Pharmaceuticals Canada has introduced 20 new medicines that have had an important impact on patients suffering from a wide variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation and osteoporosis.